pI: 9.6213 |
Length (AA): 247 |
MW (Da): 30058 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
50 | 241 | 1uan (A) | 3 | 177 | 16.00 | 0 | 0.54 | 0.91 | -0.57 |
23 | 245 | 3we7 (A) | 18 | 260 | 17.00 | 0 | 0.77 | 0.907934 | 0 |
34 | 226 | 3we7 (A) | 31 | 232 | 17.00 | 0 | 0.85 | 0.880777 | 0.18 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | sporozoite, Sporozoite. | PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, Ring, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | intra-erythrocytic - 8 hs, Female Gametocyte. | Otto TD Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128077)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G27340 | N-acetylglucosaminylphosphatidylinositol de-N-acetylase family protein |
Arabidopsis thaliana | AT3G58130 | N-acetylglucosaminylphosphatidylinositol de-N-acetylase family protein |
Babesia bovis | BBOV_III007080 | N-acetylglucosaminyl-phosphatidylinositol de-n-acetylase, putative |
Brugia malayi | Bm1_48430 | Uncharacterized LmbE-like protein, COG2120 containing protein |
Candida albicans | CaO19.4903 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Candida albicans | CaO19.12368 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Caenorhabditis elegans | CELE_Y52B11C.1 | Protein Y52B11C.1 |
Cryptosporidium parvum | cgd7_700 | N-acetylglucosaminyl-phosphatidylinositolde-N-acetylase |
Dictyostelium discoideum | DDB_G0293136 | phosphatidylinositol glycan, class L |
Drosophila melanogaster | Dmel_CG4433 | CG4433 gene product from transcript CG4433-RD |
Echinococcus granulosus | EgrG_000245500 | N acetylglucosaminyl phosphatidylinositol |
Entamoeba histolytica | EHI_015270 | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase, putative |
Echinococcus multilocularis | EmuJ_000245500 | N acetylglucosaminyl phosphatidylinositol |
Giardia lamblia | GL50803_14236 | hypothetical protein |
Homo sapiens | ENSG00000108474 | phosphatidylinositol glycan anchor biosynthesis, class L |
Leishmania braziliensis | LbrM.09.0060 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania donovani | LdBPK_090060.1 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania infantum | LinJ.09.0060 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania major | LmjF.09.0040 | N-acetyl-D-acetylglucosaminylphosphatidylinositol deacetylase |
Leishmania mexicana | LmxM.09.0040 | N-acetylglucosaminyl-phosphatidylinositol deacetylase |
Loa Loa (eye worm) | LOAG_01808 | phosphatidylinositol glycan anchor biosynthesis protein |
Mus musculus | 327942 | phosphatidylinositol glycan anchor biosynthesis, class L |
Mycobacterium tuberculosis | Rv0323c | Conserved hypothetical protein |
Neospora caninum | NCLIV_028260 | hypothetical protein |
Oryza sativa | 4337416 | Os04g0678800 |
Plasmodium berghei | PBANKA_1123600 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium falciparum | PF3D7_0624700 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium vivax | PVX_114344 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium yoelii | PY06379 | probable n-acetylglucosaminyl-phosphatidylinositol de-n-acetylase |
Saccharomyces cerevisiae | YMR281W | Gpi12p |
Schistosoma japonicum | Sjp_0304740 | ko:K03434 N-acetylglucosaminylphosphatidylinositol deacetylase [EC3.5.1.89], putative |
Schistosoma mansoni | Smp_035080 | N-acetylglucosaminyl-phosphatidylinositol de-n-acetylase |
Trypanosoma brucei gambiense | Tbg972.11.13520 | N-acetylglucosaminyl-phosphatidylinositol deacetylase, putative |
Trypanosoma brucei | Tb927.11.12080 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Trypanosoma congolense | TcIL3000.11.12710 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Trypanosoma cruzi | TcCLB.504005.20 | N-Acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase, putative |
Trypanosoma cruzi | TcCLB.511481.40 | N-Acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase, putative |
Toxoplasma gondii | TGME49_258110 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Toxoplasma gondii | TGME49_258100 | TPR repeat region protein |
Theileria parva | TP04_0615 | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu326 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.01.3900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.3900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.3900 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.3900 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YMR281W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1123600 | Plasmodium berghei | Essential | plasmo |
TGME49_258110 | Toxoplasma gondii | Probably essential | sidik |
TGME49_258100 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Plasmodium falciparum | No drug identifiers listed for this gene. | |
Annotator: | saralph@unimelb.edu.au. | Comment: | Drug: GalNCONH2-PI, GlcNCONH2-beta-PI. . | References: | 12117963 12369829 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
16 literature references were collected for this gene.